Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

diammine dicarboxylic acid platinum

Known as: DDAP cpd 
 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (3)

Aspartic AcidChondroitinOrganoplatinum Compounds
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Anticancer efficacy of p-dodecylaminophenol against high-risk and refractory neuroblastoma cells in vitro and in vivo.
Neuroblastoma is an aggressive and drug-resistant refractory cancer. The human high-risk neuroblastoma cell line, SK-N-AS (non… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
2013
2013
Paravalvular aortic regurgitation as the reason for second CoreValve bioprosthesis implantation in a patient with native bicuspid valve.
We present the case of a 70-year-old male patient who was admitted to our centre with severe symptomatic aortic stenosis. His… Expand
2010
2010
Effects of the aminophenol analogue p-Dodecylaminophenol on mouse skin.
p-Dodecylaminophenol (p-DDAP) was designed on the basis of structure-activity relationship studies on N-(4-hydroxyphenyl… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2008
2008
Diammine Dicarboxylic Acid Platinum Enhances Cytotoxicity in Platinum-Resistant Ovarian Cancer Cells through Induction of Apoptosis and S-Phase Cell Arrest
PurposePolysaccharides such as chondroitin play a potent role in tumor growth, tissue repair and angiogenesis. These properties… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE